162
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Drug Repurposing in Crohn’s Disease Using Danish Real-World Data

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 17-29 | Received 08 Dec 2023, Accepted 08 Feb 2024, Published online: 20 Feb 2024

Figures & data

Figure 1 Hazard ratio of drugs associated with an increased risk of the study outcome.

Figure 1 Hazard ratio of drugs associated with an increased risk of the study outcome.

Figure 2 Risk difference of drugs associated with an increased risk of the study outcome.

Figure 2 Risk difference of drugs associated with an increased risk of the study outcome.

Figure 3 Lasso regression for variable selection prolonging time interval from CD to the study outcome. Log(λ) = 4.5 was chosen to get the optimal number of features.

Figure 3 Lasso regression for variable selection prolonging time interval from CD to the study outcome. Log(λ) = 4.5 was chosen to get the optimal number of features.

Figure 4 Hazard ratio of drugs associated with a prolonged time interval from the initial diagnosis of CD to the study outcome.

Figure 4 Hazard ratio of drugs associated with a prolonged time interval from the initial diagnosis of CD to the study outcome.

Figure 5 Risk difference of drugs associated with an increased time interval from CD diagnosis date to the study outcome date.

Figure 5 Risk difference of drugs associated with an increased time interval from CD diagnosis date to the study outcome date.

Data Sharing Statement

Data are stored on secure servers on Statistics Denmark and cannot be shared according to Statistics Denmark regulations. Access to Statistics Denmark servers and the associated data can be granted by Statistics Denmark upon adequate permissions.